Table 1.
Descriptive Statistics Stratified by HIV Status (N = 81)
| HIV positive (n) (%) | HIV negative (n) (%) | p value | |
|---|---|---|---|
| Age (in years) | 36 (44.4) | 45 (55.6) | .48† |
| 21–35 | 14 (38.9) | 21 (46.7) | |
| ≥60 | 22 (61.1) | 24 (53.3) | |
| Gender | .21† | ||
| Male | 21 (58.3) | 20 (44.4) | |
| Female | 15 (41.7) | 25 (55.6) | |
| Race | <.001† | ||
| Black | 15 (41.7) | 6 (13.3) | |
| White | 13 (36.1) | 33 (73.3) | |
| Asian | 0 (0.0) | 4 (8.9) | |
| Other | 8 (22.2) | 2 (4.4) | |
| Ethnicity | |||
| Hispanic | 10 (27.8) | 3 (6.7) | .01† |
| Number of Co-morbidities | .04‡ | ||
| Co-morbidities (0) | 0 (0.0) | 6 (13.3) | |
| Co-morbidities (1–3) | 11 (30.6) | 17 (37.8) | |
| Co-morbidities (4–7) | 18 (50.0) | 12 (26.7) | |
| Co-morbidities (>7) | 7 (19.4) | 10 (22.2) | |
| Specific Co-morbidities | |||
| Diabetes | 8 (22.2) | 11 (24.4) | .81† |
| Metabolic syndrome (DM + HTN+ HLD) | 5 (13.9) | 11 (24.4) | .24† |
| Cardiovascular disease | 10 (27.8) | 12 (26.7) | .91† |
| Pulmonary disease | 11 (30.6) | 12 (26.7) | .70† |
| Substance use | |||
| Smoking | 9 (25.0) | 5 (11.1) | .10† |
| Recreational drugs | 9 (25.0) | 2 (4.4) | .01‡ |
| Tuberculosis risk factor | |||
| History of positive PPD/QuantiFERON | 6 (16.7) | 2 (4.6) | .13‡ |
| HIV disease factors | |||
| CD4 count >200/mm3 | 35 (97.2) | Not measured | |
| On antiretroviral therapy | 34 (94.4) | N/A | |
| HIV VL > 100 | 4 (11.1) | N/A | |
| % life span HIV | *29.7 (19.0, 43.7) | 0.0 (0.0, 0.0) |
Note: Demographic information for HIV-positive and HIV-negative cohorts. DM = diabetes mellitus; HLD = hyperlipidemia; HTN = hypertension; PPD = purified protein derivative.
*The value of % life span HIV (since diagnosis) represented in the table represents an interquartile range, with the median (25 percentile, 75 percentile). p values less than or equal to .05 were considered significant.
† p values calculated using the Pearson chi-square test
‡ p values calculated using the Fisher exact test.